Gene therapy of malignant gliomas: a phase I study of IL-4-HSV-TK gene-modified autologous tumor to elicit an immune response.
Okada H, Pollack IF, Lotze MT, Lunsford LD, Kondziolka D, Lieberman F, Schiff D, Attanucci J, Edington H, Chambers W, Robbins P, Baar J, Kinzler D, Whiteside T, Elder E.
Okada H, et al. Among authors: pollack if.
Hum Gene Ther. 2000 Mar 1;11(4):637-53. doi: 10.1089/10430340050015824.
Hum Gene Ther. 2000.
PMID: 10724042
Clinical Trial.
No abstract available.